Citius Pharmaceuticals to Highlight its Phase 3 Clinical Trial Product Mino-Lok® at Benzinga Biotech Small Cap Conference on March 25
Stock Information for Citius Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.